BroadOak Capital Partners is an investor in Codis – formerly Particle Dynamics.
The full press release is below.
ST. LOUIS, Oct. 14, 2025 /PRNewswire/ — Codis officially launches as a new global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies. Formed through the integration of Particle Dynamics in the US and the Haverhill, UK spray drying facility previously operated by EUROAPI, Codis combines decades of regulatory expertise and manufacturing strength under one brand.
With facilities in St. Louis, MO, Seymour, IN and Haverhill, UK, Codis offers:
- Over 5000 metric tons/year of spray drying output capacity
- 30 products with 50 pharma global customers
- 30 years of successful regulatory track record
- Audited and approved by 6 international regulatory agencies
- 300+ employees worldwide
“Codis is built on a foundation of scale, quality, and global reach,” said Nicolas Fortin, Codis CEO. “With a total of 40,000 m2 of manufacturing space, three GMP facilities and with 7 of regulatory approvals achieved, we are uniquely positioned to help pharmaceutical innovators accelerate therapies from development to market.”
Acquired from EUROAPI in June 2025, Haverhill, UK facility brings over 30 years of expertise in spray drying, continuous flow chemistry, and regulatory compliance. The site also serves as one of the world’s primary manufacturers of Sevelamer, underscoring its capability to support high-quality, globally approved products.
The name Codis, derived from the Latin codex (“law” or “system”), reflects the company’s commitment to compliance, reliability, and problem-solving for its global partners.
